Market cap
$12.5m
End-of-day close multiplied by current shares on issue.
Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$12.5m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
9.63x
Recent market cap compared with trailing earnings.
EPS
0.02
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
2.35x
Enterprise value compared with recent EBITDA.
P/FCF
2.7x
Market cap compared with recent free cash flow.
P/B
0.67x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY26 vs FY25
Revenue
$55.2m
-2.6% ↓ vs $56.6m
EBITDA
$8m
+10.3% ↑ vs $7.3m
Net profit after tax
$1.3m
+208.3% ↑ vs −$1.2m
Net cash inflow from operating activities
$6.9m
-3.2% ↓ vs $7.1m
Profit before tax
$1.8m
+228.6% ↑ vs −$1.4m
Total assets
$49.6m
-3.9% ↓ vs $51.6m
What changed
Revenue softened to $55.2m from $56.6m, so the swing was driven by margin rather than top-line growth: EBITDA rose to $8.0m from $7.3m, and EBITDA margin reached 14.5%, just above the 9.8%-14.2% band Annolyse's historical baseline shows over the prior five years.
Cash generation held up: operating cash flow was $6.9m versus $7.1m, and net debt fell to $6.3m from $7.2m, leaving net debt/EBITDA at 0.79x against a historical mean of 2.07x. Capex stepped up to $2.2m from $1.3m, a 69% increase that took capex intensity to 4.1% of revenue from 2.3%.
What matters
Operating earnings expanded with revenue down, indicating cost or mix improvement rather than volume recovery. EBITDA margin at 14.5% sits above the supplied historical range, and PBT margin of 3.3% is the first positive reading in the five-year baseline (prior range -19.2% to -2.5%). The durability question is whether this margin level can hold without revenue growth resuming.
Tax line distorts the headline. The current effective tax rate of -27.5% sits well below the historical mean of 27.8%, and the calculation pass flags tax distortion in the result. PBT is therefore the cleaner read on operating performance; the NPAT swing should not be taken as untaxed economic improvement, and the 16.8 percentage-point gap between PBT and NPAT growth is tax-driven rather than operational.
Leverage materially below the historical range. Net debt/EBITDA of 0.79x is below the 1.0x-4.0x band in the historical baseline. Gross borrowings fell to $8.0m from $9.0m and equity rose to $18.7m, which means balance-sheet flexibility has improved materially - relevant given the step-up in capex intensity.
Expectations
Half-year context shows HY26 captured 52.7% of full-year revenue but only 39.2% of EBITDA, implying the second half was margin-stronger on a smaller revenue base - a shape that frames durability questions about the FY26 EBITDA margin reading.
The 69% capex step-up to $2.2m and the rise in capex intensity to 4.1% suggest reinvestment is underway, but the release excerpts do not disclose what is being funded or the expected return profile. Without that, this briefing cannot tie the capex shape to a forward earnings or revenue path.
Quality of result
However, OCF fell modestly while EBITDA rose, meaning conversion deteriorated versus the prior comparable even though the absolute level remains healthy. A small working-capital absorption of $0.1m sits at the upper edge of the historical pattern, where prior years typically released around $1.8m of cash, so working capital did not flatter the cash result.
Free cash flow pre-lease was $4.6m versus $5.8m, with the decline explained mostly by higher capex rather than weaker operations. The reported NPAT improvement carries a tax-benefit element that should not be extrapolated, but EBITDA, PBT, and operating cash flow all sit at or near multi-year highs on the supplied baseline, which suggests the underlying step-change is operational rather than accounting-driven. Capex intensity has nearly doubled, so future free-cash-flow conversion will depend on whether the heavier investment cadence persists.
Unresolved
This briefing cannot assess the operational drivers behind the margin step-up or the strategic intent behind the capex increase because the supplied release excerpts and context do not disclose them.
Chat
Ask follow-up questions about Savor's FY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Savor Annual Report 2026
FY26 / financial reportSavor Annual Results - Market Announcement
FY26 / results releaseSavor Annual Results - NZX Appendix 2
FY26 / results announcementSavor Annual Report 2025
FY25 / financial reportSavor Annual Results - Market Announcement
FY25 / results releaseSavor Annual Results - NZX Appendix 2
FY25 / results announcementSavor Interim Financial Statements
HY26 / financial reportSavor Interim Results - Appendix 2
HY26 / results announcementSavor Interim Results Announcement
HY26 / results releaseSavor 2023 Annual Meeting results
HY26 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 85.8% of EBITDA to operating cash flow, -11.9pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 16.8pp, with a distortion flag in the result.
Leverage and balance-sheet risk
Net debt / EBITDA is 0.79x, -0.20x versus the prior comparable period.
ROE and capital efficiency
ROE was 6.9%, +13.9pp versus the prior comparable period.
Get the next Savor briefing and related NZX reporting-season updates by email.